Trial record 1 of 1 for:    EFC 11570
Previous Study | Return to List | Next Study

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01663402
Recruitment Status : Completed
First Posted : August 13, 2012
Last Update Posted : February 14, 2018
Regeneron Pharmaceuticals
Information provided by (Responsible Party):